首页 > 最新文献

Journal of ethnopharmacology最新文献

英文 中文
Camellia japonica hyperoside exhibits anti-age-related macular degeneration effects in an ARPE-19 cell model by inhibiting apoptosis via JNK-Nrf2/HO-1 activation 山茶金丝桃苷通过JNK-Nrf2/HO-1活化抑制凋亡,在ARPE-19细胞模型中表现出抗年龄相关性黄斑变性的作用。
IF 5.4 2区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-02-06 DOI: 10.1016/j.jep.2026.121305
Seung-Yub Song , Duc Dat Le , Mina Lee , Seung-Sik Cho , Dae-Hun Park

Ethnopharmacological relevance

Camellia japonica is recognized for its edible and therapeutic value in East Asia, and has anti-inflammatory, antioxidative, and antiasthmatic properties. However, the active compound and the modes of action are unclear.
Aim of the study: To evaluate the anti-AMD effect of hyperoside isolated from the leaves and twigs of Camellia japonica and to explore the underlying mechanisms using an ARPE-19 AMD cell model.

Material and methods

The hyperoside content in the extracts was evaluated using feature-based molecular network and UHPLC-MS/MS system. Network pharmacology was used to predict the interactions of hyperoside with AMD-related signaling pathways and the underlying mechanisms. For in vitro evaluation of the anti-AMD effects, ARPE-19 cells were divided into six treatment groups: CON, no treatment; A2E, AMD induction using 30 μM A2E and 20 mW/cm2 blue light treatment; Lutein, treatment with 25 μM lutein as a positive control; and three Hyperoside groups, treated with 37.5, 75, or 150 μM hyperoside. The antiapoptotic effect of hyperoside was evaluated using flow cytometry and TUNEL assays, and the intrinsic apoptotic pathway proteins (Bcl-xL, Bad, and Bim) were analyzed via western blotting. The interactions of hyperoside with JNK and p38 MAPKs were determined using western blotting, and molecular docking. The antioxidative effect of hyperoside was measured via DPPH and ABTS radical scavenging assays; Nrf2/HO-1 activation and SOD-1 stimulation were analyzed using western blotting and immunofluorescence assay. The anticarbonyl effect (4-HNE and MDA) was measured using western blotting.

Results

Hyperoside was nontoxic to ARPE-19 cells up to 150 μM. It dose-dependently decreased A2E and blue light-induced AMD in ARPE-19 cells by upregulating the antiapoptotic Bcl-2 protein (Bcl-xL) and downregulating the proapoptotic Bcl-2 proteins (Bad and Bim). Hyperoside dephosphorylated JNK and p38 MAPKs in a dose-dependent manner, eradicated DPPH and ABTS radicals, and activated Nrf2/HO-1 and SOD-1. It also decreased the levels of 4-HNE and MDA.

Conclusion

We conclude that C. japonica hyperoside could be a promising anti-AMD drug.
民族药理学相关性:山茶在东亚因其食用和治疗价值而被公认,并具有抗炎、抗氧化和平喘的特性。然而,活性化合物和作用方式尚不清楚。目的:利用ARPE-19型AMD细胞模型,评价从山茶叶片和细枝中分离得到的金丝桃苷的抗AMD作用,并探讨其作用机制。材料与方法:采用基于特征的分子网络和UHPLC-MS/MS系统对金丝桃苷的含量进行测定。网络药理学用于预测金丝桃苷与amd相关信号通路的相互作用及其潜在机制。为了体外评估抗amd作用,将ARPE-19细胞分为6个治疗组:CON,未治疗;A2E, AMD感应采用30 μM A2E和20 mW/cm2蓝光处理;叶黄素,25 μM叶黄素处理为阳性对照;和三个金丝桃苷组,分别用37.5、75或150 μM的金丝桃苷处理。流式细胞术和TUNEL检测金丝桃苷的抗凋亡作用,western blotting检测凋亡通路内固有蛋白(Bcl-xL、Bad、Bim)。金丝桃苷与JNK和p38 MAPKs的相互作用通过western blotting和分子对接来确定。通过DPPH和ABTS自由基清除实验检测金丝桃苷的抗氧化作用;western blotting和免疫荧光法分析Nrf2/HO-1激活和SOD-1刺激。采用免疫印迹法测定抗羰基效应(4-HNE和MDA)。结果:金丝桃苷对150 μM以内的ARPE-19细胞无毒性。它通过上调抗凋亡Bcl-2蛋白(Bcl-xL)和下调促凋亡Bcl-2蛋白(Bad和Bim),呈剂量依赖性地降低A2E和蓝光诱导的ARPE-19细胞AMD。金丝桃苷以剂量依赖的方式使JNK和p38 MAPKs去磷酸化,根除DPPH和ABTS自由基,激活Nrf2/HO-1和SOD-1。同时降低4-HNE和MDA的水平。结论:川芎金丝桃苷是一种很有前途的抗黄斑变性药物。
{"title":"Camellia japonica hyperoside exhibits anti-age-related macular degeneration effects in an ARPE-19 cell model by inhibiting apoptosis via JNK-Nrf2/HO-1 activation","authors":"Seung-Yub Song ,&nbsp;Duc Dat Le ,&nbsp;Mina Lee ,&nbsp;Seung-Sik Cho ,&nbsp;Dae-Hun Park","doi":"10.1016/j.jep.2026.121305","DOIUrl":"10.1016/j.jep.2026.121305","url":null,"abstract":"<div><h3>Ethnopharmacological relevance</h3><div><em>Camellia japonica</em> is recognized for its edible and therapeutic value in East Asia, and has anti-inflammatory, antioxidative, and antiasthmatic properties. However, the active compound and the modes of action are unclear.</div><div><em>Aim of the study</em>: To evaluate the anti-AMD effect of hyperoside isolated from the leaves and twigs of <em>Camellia japonica</em> and to explore the underlying mechanisms using an ARPE-19 AMD cell model.</div></div><div><h3>Material and methods</h3><div>The hyperoside content in the extracts was evaluated using feature-based molecular network and UHPLC-MS/MS system. Network pharmacology was used to predict the interactions of hyperoside with AMD-related signaling pathways and the underlying mechanisms. For <em>in vitro</em> evaluation of the anti-AMD effects, ARPE-19 cells were divided into six treatment groups: CON, no treatment; A2E, AMD induction using 30 μM A2E and 20 mW/cm<sup>2</sup> blue light treatment; Lutein, treatment with 25 μM lutein as a positive control; and three Hyperoside groups, treated with 37.5, 75, or 150 μM hyperoside. The antiapoptotic effect of hyperoside was evaluated using flow cytometry and TUNEL assays, and the intrinsic apoptotic pathway proteins (Bcl-xL, Bad, and Bim) were analyzed via western blotting. The interactions of hyperoside with JNK and p38 MAPKs were determined using western blotting, and molecular docking. The antioxidative effect of hyperoside was measured via DPPH and ABTS radical scavenging assays; Nrf2/HO-1 activation and SOD-1 stimulation were analyzed using western blotting and immunofluorescence assay. The anticarbonyl effect (4-HNE and MDA) was measured using western blotting.</div></div><div><h3>Results</h3><div>Hyperoside was nontoxic to ARPE-19 cells up to 150 μM. It dose-dependently decreased A2E and blue light-induced AMD in ARPE-19 cells by upregulating the antiapoptotic Bcl-2 protein (Bcl-xL) and downregulating the proapoptotic Bcl-2 proteins (Bad and Bim). Hyperoside dephosphorylated JNK and p38 MAPKs in a dose-dependent manner, eradicated DPPH and ABTS radicals, and activated Nrf2/HO-1 and SOD-1. It also decreased the levels of 4-HNE and MDA.</div></div><div><h3>Conclusion</h3><div>We conclude that <em>C. japonica</em> hyperoside could be a promising anti-AMD drug.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"362 ","pages":"Article 121305"},"PeriodicalIF":5.4,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Buyang Huanwu Decoction attenuates vascular aging by suppressing the pathway of neutrophil extracellular trap formation via modulation of the HMGB1/TLR4/p38 signaling pathway 补阳还五汤通过调节HMGB1/TLR4/p38信号通路抑制中性粒细胞胞外陷阱形成途径减缓血管衰老
IF 5.4 2区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-02-06 DOI: 10.1016/j.jep.2026.121315
Nan Xiao , Jinsong Gao , Yutong Yang , Chenghui Li , Xuejuan Shen , Xiangyu Chen , Xiaodie Chen , Yanbin Pan , Huiqun Huang , Simin Yang , Shuting Zeng , Xiaodong Duan , Yongan Deng , Chengkai Chen , Yixuan Huang , Danping Huang , Zunpeng Shu , Li Zhang

Ethnopharmacological relevance

Vascular aging is a significant driver of age-related cardiovascular diseases, in which the immune-inflammatory response driven by excessive formation of neutrophil extracellular traps (NETs) is a core process accelerating this progression. Buyang Huanwu Decoction (BHD) is a classic traditional Chinese medicine (TCM) formula widely used for treating cardio-cerebrovascular diseases, but whether it acts through modulating NET-driven vascular aging is unknown.

Aim of the study

This study aims to investigate the mechanism by which BHD delays vascular aging, focusing on the NETs formation pathway.

Materials and methods

Based on a D-galactose-induced aging mouse model, this study focused on neutrophils and combined transcriptomics, network pharmacology and molecular biology methods to explore the mechanism of BHD in delaying vascular aging.

Results

The present study identified 23 major chemical constituents in BHD and demonstrated its efficacy in ameliorating aging phenotypes in a D-galactose-induced aging mouse model. BHD treatment significantly alleviated aortic structural degeneration, reduced oxidative stress and inflammatory cytokine levels, and downregulated key senescence markers including p16 and p21. Integrated multi-omics analysis implicated NET suppression as a primary mechanism underlying the anti-aging benefits of BHD. Both in vivo and in vitro experiments confirmed that BHD inhibits NETosis by modulating the HMGB1/TLR4/p38 signaling pathway, leading to reduced expression of critical NET components. Notably, HMGB1 overexpression partially reversed the inhibitory effects of BHD on NETosis, establishing HMGB1 as a key effector molecule.

Conclusion

For the first time, our findings unveil a novel mechanism whereby BHD alleviates vascular aging by modulating the immune microenvironment through inhibition of the HMGB1–TLR4–p38–NETs cascade. These findings provide a novel immunomodulatory perspective on BHD and highlight its potential as a holistic therapeutic strategy against vascular aging.
民族药理学相关性:血管老化是年龄相关心血管疾病的重要驱动因素,其中由中性粒细胞胞外陷阱(NETs)过度形成驱动的免疫炎症反应是加速这一进展的核心过程。补阳还五汤(BHD)是一种广泛用于治疗心脑血管疾病的经典中药方剂,但其是否通过调节net驱动的血管衰老起作用尚不清楚。研究目的:本研究旨在探讨BHD延缓血管衰老的机制,重点研究NETs的形成途径。材料与方法:本研究以d -半乳糖诱导衰老小鼠模型为基础,以中性粒细胞为研究对象,结合转录组学、网络药理学和分子生物学等方法,探讨BHD延缓血管衰老的机制。结果:本研究鉴定了BHD的23种主要化学成分,并在d -半乳糖诱导的衰老小鼠模型中证明了其改善衰老表型的功效。BHD治疗显著缓解了主动脉结构变性,降低了氧化应激和炎症细胞因子水平,下调了关键衰老标志物p16和p21。综合多组学分析表明,NET抑制是BHD抗衰老作用的主要机制。体内和体外实验均证实BHD通过调节HMGB1/TLR4/p38信号通路抑制NETosis,导致关键NET组分的表达降低。值得注意的是,HMGB1过表达部分逆转了BHD对NETosis的抑制作用,表明HMGB1是一个关键的效应分子。结论:我们的发现首次揭示了BHD通过抑制HMGB1-TLR4-p38-NETs级联调节免疫微环境来缓解血管衰老的新机制。这些发现为BHD提供了一种新的免疫调节视角,并强调了其作为对抗血管衰老的整体治疗策略的潜力。
{"title":"Buyang Huanwu Decoction attenuates vascular aging by suppressing the pathway of neutrophil extracellular trap formation via modulation of the HMGB1/TLR4/p38 signaling pathway","authors":"Nan Xiao ,&nbsp;Jinsong Gao ,&nbsp;Yutong Yang ,&nbsp;Chenghui Li ,&nbsp;Xuejuan Shen ,&nbsp;Xiangyu Chen ,&nbsp;Xiaodie Chen ,&nbsp;Yanbin Pan ,&nbsp;Huiqun Huang ,&nbsp;Simin Yang ,&nbsp;Shuting Zeng ,&nbsp;Xiaodong Duan ,&nbsp;Yongan Deng ,&nbsp;Chengkai Chen ,&nbsp;Yixuan Huang ,&nbsp;Danping Huang ,&nbsp;Zunpeng Shu ,&nbsp;Li Zhang","doi":"10.1016/j.jep.2026.121315","DOIUrl":"10.1016/j.jep.2026.121315","url":null,"abstract":"<div><h3>Ethnopharmacological relevance</h3><div>Vascular aging is a significant driver of age-related cardiovascular diseases, in which the immune-inflammatory response driven by excessive formation of neutrophil extracellular traps (NETs) is a core process accelerating this progression. Buyang Huanwu Decoction (BHD) is a classic traditional Chinese medicine (TCM) formula widely used for treating cardio-cerebrovascular diseases, but whether it acts through modulating NET-driven vascular aging is unknown.</div></div><div><h3>Aim of the study</h3><div>This study aims to investigate the mechanism by which BHD delays vascular aging, focusing on the NETs formation pathway.</div></div><div><h3>Materials and methods</h3><div>Based on a D-galactose-induced aging mouse model, this study focused on neutrophils and combined transcriptomics, network pharmacology and molecular biology methods to explore the mechanism of BHD in delaying vascular aging.</div></div><div><h3>Results</h3><div>The present study identified 23 major chemical constituents in BHD and demonstrated its efficacy in ameliorating aging phenotypes in a D-galactose-induced aging mouse model. BHD treatment significantly alleviated aortic structural degeneration, reduced oxidative stress and inflammatory cytokine levels, and downregulated key senescence markers including p16 and p21. Integrated multi-omics analysis implicated NET suppression as a primary mechanism underlying the anti-aging benefits of BHD. Both in vivo and in vitro experiments confirmed that BHD inhibits NETosis by modulating the HMGB1/TLR4/p38 signaling pathway, leading to reduced expression of critical NET components. Notably, HMGB1 overexpression partially reversed the inhibitory effects of BHD on NETosis, establishing HMGB1 as a key effector molecule.</div></div><div><h3>Conclusion</h3><div>For the first time, our findings unveil a novel mechanism whereby BHD alleviates vascular aging by modulating the immune microenvironment through inhibition of the HMGB1–TLR4–p38–NETs cascade. These findings provide a novel immunomodulatory perspective on BHD and highlight its potential as a holistic therapeutic strategy against vascular aging.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"362 ","pages":"Article 121315"},"PeriodicalIF":5.4,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tianwangbuxiandan decoction alleviates constipation and associated emotional disorders via regulating the brain-gut axis: Involving MAPK/ERK/JNK signaling pathways 天王补仙丹汤通过调节脑肠轴:参与MAPK/ERK/JNK信号通路缓解便秘及相关情绪障碍
IF 5.4 2区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-02-05 DOI: 10.1016/j.jep.2026.121308
Shaoliang Li , Pengning Wu , Yue Wang, Dehao Wang, Haihua Qian, Dan Zhang

Ethnopharmacological relevance

Tianwang Buxin Dan (TWBXD) is a classical Chinese formula traditionally prescribed to “nourish Yin, calm the mind and relieve bowel stagnation” in disorders characterized by heart-kidney disharmony, insomnia, anxiety, and constipation. However, the mechanistic basis associating its gut-regulating and emotion-modulating effects along the gut-brain axis remains unclear.

Aim of the study

To investigate whether TWBXD ameliorates functional constipation comorbid with emotional disturbances by modulating mitogen-activated protein kinase/Extracellular Signal-Regulated Kinase/c-Jun N-terminal Kinase (MAPK/ERK/JNK) signaling, hypothalamic-pituitary-adrenal (HPA)-axis activity, and autophagy-related mitochondrial integrity in the colon and hippocampus.

Materials and methods

A diphenoxylate-induced rat model of functional constipation with anxiety/depression-like behavior was treated with low, medium, or high doses of TWBXD. Intestinal transit, fecal parameters, and distal colonic transit were also assessed. Emotional behaviors were evaluated using open-field and elevated plus-maze tests. Colonic and hippocampal histopathology and ultrastructure were examined using hematoxylin and eosin staining, Nissl staining, and transmission electron microscopy. Serum corticotropin-releasing factor (CRF), adrenocorticotropic hormone (ACTH), and corticosterone (CORT) levels were measured using enzyme-linked immunosorbent assay. MAPK/ERK/JNK-related proteins and brain-derived neurotrophic factor (BDNF) were analyzed by Western blotting. The major chemical constituents of TWBXD were characterized using ultra-high-performance liquid chromatography-tandem mass spectrometry(UHPLC–MS/MS).

Results

TWBXD dose-dependently improved intestinal transit, fecal moisture, and body weight gain, and alleviated anxiety-/depression-like behaviors. TWBXD preserved colonic mucosal architecture and hippocampal neuronal integrity, mitigated mitochondrial swelling and excessive autophagic vacuole formation, downregulated colonic phosphorylated ERK (p-ERK), phosphorylated JNK, and phosphorylated p38, restored hippocampal BDNF expression while normalizing p-ERK levels, and reduced serum CRF, ACTH, and CORT levels.

Conclusion

TWBXD exerts multi-target therapeutic effects on functional constipation with emotional disturbances by suppressing MAPK/ERK/JNK overactivation, normalizing HPA-axis hyperactivity, and protecting mitochondrial structure and autophagy along the gut-brain axis, providing mechanistic support for its traditional use in gut-brain-related disorders.
民族药理学相关性:天王补心丹(TWBXD)是一种中国古典方剂,传统上用于“养阴、平心、通肠”,以治疗心肾不和、失眠、焦虑和便秘为特征的疾病。然而,其肠道调节和情绪调节作用在肠-脑轴上的机制基础仍不清楚。研究目的:探讨TWBXD是否通过调节丝裂原活化蛋白激酶/细胞外信号调节激酶/c-Jun n-末端激酶(MAPK/ERK/JNK)信号、下丘脑-垂体-肾上腺(HPA)轴活性以及结肠和海马中自噬相关的线粒体完整性来改善功能性便秘伴情绪障碍。材料和方法:采用低、中、高剂量TWBXD治疗地苯氧甲酯诱导的功能性便秘大鼠焦虑/抑郁样行为模型。肠运输、粪便参数和远端结肠运输也进行了评估。情绪行为评估采用开放场地和升高+迷宫测试。采用苏木精染色、伊红染色、尼氏染色和透射电镜对大鼠结肠和海马进行组织病理学和超微结构检查。采用酶联免疫吸附法测定血清促肾上腺皮质激素释放因子(CRF)、促肾上腺皮质激素(ACTH)和皮质酮(CORT)水平。Western blotting检测MAPK/ERK/ jnk相关蛋白和脑源性神经营养因子(BDNF)。采用超高效液相色谱-串联质谱(UHPLC-MS/MS)对其主要化学成分进行了表征。结果:TWBXD剂量依赖性改善肠道运输、粪便水分和体重增加,并缓解焦虑/抑郁样行为。TWBXD保留了结肠粘膜结构和海马神经元的完整性,减轻了线粒体肿胀和过度自噬液泡的形成,下调了结肠磷酸化ERK (p-ERK),磷酸化JNK和磷酸化p38,恢复了海马BDNF表达,使p-ERK水平正常化,降低了血清CRF、ACTH和CORT水平。结论:TWBXD通过抑制MAPK/ERK/JNK过激活、使hpa轴高活性正常化、保护肠-脑轴线粒体结构和自噬,对情绪性障碍的功能性便秘具有多靶点治疗作用,为其在肠-脑相关疾病中的传统应用提供了机制支持。
{"title":"Tianwangbuxiandan decoction alleviates constipation and associated emotional disorders via regulating the brain-gut axis: Involving MAPK/ERK/JNK signaling pathways","authors":"Shaoliang Li ,&nbsp;Pengning Wu ,&nbsp;Yue Wang,&nbsp;Dehao Wang,&nbsp;Haihua Qian,&nbsp;Dan Zhang","doi":"10.1016/j.jep.2026.121308","DOIUrl":"10.1016/j.jep.2026.121308","url":null,"abstract":"<div><h3>Ethnopharmacological relevance</h3><div>Tianwang Buxin Dan (TWBXD) is a classical Chinese formula traditionally prescribed to “nourish Yin, calm the mind and relieve bowel stagnation” in disorders characterized by heart-kidney disharmony, insomnia, anxiety, and constipation. However, the mechanistic basis associating its gut-regulating and emotion-modulating effects along the gut-brain axis remains unclear.</div></div><div><h3>Aim of the study</h3><div>To investigate whether TWBXD ameliorates functional constipation comorbid with emotional disturbances by modulating mitogen-activated protein kinase/Extracellular Signal-Regulated Kinase/c-Jun N-terminal Kinase (MAPK/ERK/JNK) signaling, hypothalamic-pituitary-adrenal (HPA)-axis activity, and autophagy-related mitochondrial integrity in the colon and hippocampus.</div></div><div><h3>Materials and methods</h3><div>A diphenoxylate-induced rat model of functional constipation with anxiety/depression-like behavior was treated with low, medium, or high doses of TWBXD. Intestinal transit, fecal parameters, and distal colonic transit were also assessed. Emotional behaviors were evaluated using open-field and elevated plus-maze tests. Colonic and hippocampal histopathology and ultrastructure were examined using hematoxylin and eosin staining, Nissl staining, and transmission electron microscopy. Serum corticotropin-releasing factor (CRF), adrenocorticotropic hormone (ACTH), and corticosterone (CORT) levels were measured using enzyme-linked immunosorbent assay. MAPK/ERK/JNK-related proteins and brain-derived neurotrophic factor (BDNF) were analyzed by Western blotting. The major chemical constituents of TWBXD were characterized using ultra-high-performance liquid chromatography-tandem mass spectrometry(UHPLC–MS/MS).</div></div><div><h3>Results</h3><div>TWBXD dose-dependently improved intestinal transit, fecal moisture, and body weight gain, and alleviated anxiety-/depression-like behaviors. TWBXD preserved colonic mucosal architecture and hippocampal neuronal integrity, mitigated mitochondrial swelling and excessive autophagic vacuole formation, downregulated colonic phosphorylated ERK (p-ERK), phosphorylated JNK, and phosphorylated p38, restored hippocampal BDNF expression while normalizing p-ERK levels, and reduced serum CRF, ACTH, and CORT levels.</div></div><div><h3>Conclusion</h3><div>TWBXD exerts multi-target therapeutic effects on functional constipation with emotional disturbances by suppressing MAPK/ERK/JNK overactivation, normalizing HPA-axis hyperactivity, and protecting mitochondrial structure and autophagy along the gut-brain axis, providing mechanistic support for its traditional use in gut-brain-related disorders.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"362 ","pages":"Article 121308"},"PeriodicalIF":5.4,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standardized alkali-treated Euglena gracilis β-glucan mitigates PM2.5-induced pulmonary and cerebral injury through NF-κB, NRF2, and CREB–BDNF–TrkB pathways 标准化碱处理的薄叶草β-葡聚糖通过NF-κB、NRF2和CREB-BDNF-TrkB通路减轻pm2.5诱导的肺和脑损伤。
IF 5.4 2区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-02-05 DOI: 10.1016/j.jep.2026.121276
Ye-Lim You , Ha-Jun Byun , Jin-Young Jeon , Bo-Ra Kim , Ji Eun Hwang , Jun Hee Lee , Hyeon-Son Choi

Ethnopharmacological relevance

Euglena gracilis has a history of traditional use in East Asia as a functional food with reported antioxidant and immunomodulatory benefits. This study investigates the pharmacological potential of its bioactive component, standardized alkali-treated β-glucan (AEGB), in mitigating systemic toxicity induced by environmental pollutants, providing a rationale to investigate its protective effects in the context of particulate matter (PM2.5)-induced injury.

Aim of the study

To evaluate the protective effects of standardized alkali-treated E. gracilis β-glucan (AEGB) against PM2.5-induced pulmonary and cerebral toxicity in BALB/c mice via the lung–brain axis.

Materials and methods

AEGB was prepared and standardized to contain 93% (w/w) β-glucan. BALB/c mice were intranasally exposed to PM2.5 and orally administered AEGB (200/400 mg/kg). Efficacy was evaluated via BALF analysis, histopathology, and immunoblotting, focusing on MAPK, NF-κB, NRF2–HO-1, and CREB–BDNF–TrkB pathways.

Results

AEGB exhibited higher antioxidant activity than untreated β-glucan. In PM2.5-exposed mice, AEGB (400 mg/kg) reduced inflammatory cells in BALF by 69.5% and suppressed lung pro-inflammatory cytokines (IL-1β, IL-6). Histologically, it attenuated bronchial thickening and mucin production. In the brain, AEGB downregulated NF-κB by 72.1% and restored hippocampal neuronal area (+41.1%) and tight junction marker expression associated with blood–brain barrier integrity. At the molecular level, AEGB inhibited pulmonary MAPK/NF-κB and activated NRF2–HO-1, while enhancing the cerebral CREB–BDNF–TrkB neurotrophic pathway.

Conclusions

AEGB mitigates PM2.5-induced damage in both lung and brain tissues, accompanied by anti-inflammatory and neuroprotective responses consistent with inter-organ inflammatory/oxidative pathways relevant to the lung–brain axis. These findings validate the potential of E. gracilis-derived β-glucan as a functional agent for preserving respiratory and neural health.
民族药理学相关性:细叶菊在东亚有传统的使用历史,作为一种功能性食品,据报道具有抗氧化和免疫调节作用。本研究探讨了其生物活性成分,标准化碱处理β-葡聚糖(AEGB)在减轻环境污染物引起的全身毒性方面的药理学潜力,为研究其在颗粒物(PM2.5)引起的损伤中的保护作用提供了理论依据。研究目的:通过肺-脑轴评价标准化碱处理的薄叶泻子β-葡聚糖(AEGB)对pm2.5诱导的BALB/c小鼠肺和脑毒性的保护作用。材料和方法:制备egb,并将其标准化为含有93% (w/w) β-葡聚糖。BALB/c小鼠鼻内暴露于PM2.5,并口服AEGB (200/400 mg/kg)。通过BALF分析、组织病理学和免疫印迹来评估疗效,重点关注MAPK、NF-κB、NRF2-HO-1和CREB-BDNF-TrkB通路。结果:与未处理的β-葡聚糖相比,egb具有更高的抗氧化活性。在pm2.5暴露的小鼠中,AEGB (400 mg/kg)可使BALF中的炎症细胞减少69.5%,并抑制肺促炎细胞因子(IL-1β, IL-6)。组织学上,它减轻了支气管增厚和粘蛋白的产生。在大脑中,AEGB下调NF-κB 72.1%,恢复海马神经元面积(+41.1%)和与血脑屏障完整性相关的紧密连接标记物表达。在分子水平上,AEGB抑制肺MAPK/NF-κB,激活NRF2-HO-1,同时增强脑CREB-BDNF-TrkB神经营养通路。结论:AEGB减轻了pm2.5引起的肺和脑组织损伤,并伴有与肺-脑轴相关的器官间炎症/氧化途径一致的抗炎和神经保护反应。这些发现证实了股薄叶菊衍生的β-葡聚糖作为一种保护呼吸和神经健康的功能剂的潜力。
{"title":"Standardized alkali-treated Euglena gracilis β-glucan mitigates PM2.5-induced pulmonary and cerebral injury through NF-κB, NRF2, and CREB–BDNF–TrkB pathways","authors":"Ye-Lim You ,&nbsp;Ha-Jun Byun ,&nbsp;Jin-Young Jeon ,&nbsp;Bo-Ra Kim ,&nbsp;Ji Eun Hwang ,&nbsp;Jun Hee Lee ,&nbsp;Hyeon-Son Choi","doi":"10.1016/j.jep.2026.121276","DOIUrl":"10.1016/j.jep.2026.121276","url":null,"abstract":"<div><h3>Ethnopharmacological relevance</h3><div><em>Euglena gracilis</em> has a history of traditional use in East Asia as a functional food with reported antioxidant and immunomodulatory benefits. This study investigates the pharmacological potential of its bioactive component, standardized alkali-treated β-glucan (AEGB), in mitigating systemic toxicity induced by environmental pollutants, providing a rationale to investigate its protective effects in the context of particulate matter (PM2.5)-induced injury.</div></div><div><h3>Aim of the study</h3><div>To evaluate the protective effects of standardized alkali-treated <em>E. gracilis</em> β-glucan (AEGB) against PM2.5-induced pulmonary and cerebral toxicity in BALB/c mice via the lung–brain axis.</div></div><div><h3>Materials and methods</h3><div>AEGB was prepared and standardized to contain 93% (w/w) β-glucan. BALB/c mice were intranasally exposed to PM2.5 and orally administered AEGB (200/400 mg/kg). Efficacy was evaluated via BALF analysis, histopathology, and immunoblotting, focusing on MAPK, NF-κB, NRF2–HO-1, and CREB–BDNF–TrkB pathways.</div></div><div><h3>Results</h3><div>AEGB exhibited higher antioxidant activity than untreated β-glucan. In PM2.5-exposed mice, AEGB (400 mg/kg) reduced inflammatory cells in BALF by 69.5% and suppressed lung pro-inflammatory cytokines (IL-1β, IL-6). Histologically, it attenuated bronchial thickening and mucin production. In the brain, AEGB downregulated NF-κB by 72.1% and restored hippocampal neuronal area (+41.1%) and tight junction marker expression associated with blood–brain barrier integrity. At the molecular level, AEGB inhibited pulmonary MAPK/NF-κB and activated NRF2–HO-1, while enhancing the cerebral CREB–BDNF–TrkB neurotrophic pathway.</div></div><div><h3>Conclusions</h3><div>AEGB mitigates PM2.5-induced damage in both lung and brain tissues, accompanied by anti-inflammatory and neuroprotective responses consistent with inter-organ inflammatory/oxidative pathways relevant to the lung–brain axis. These findings validate the potential of <em>E. gracilis</em>-derived β-glucan as a functional agent for preserving respiratory and neural health.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"362 ","pages":"Article 121276"},"PeriodicalIF":5.4,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phytochemical profiling, anti-virulence effects, and antibacterial mechanisms of Myrothamnus flabellifolius (Welw.) extracts 黄花密菇(Myrothamnus flabellifolius, Welw.)提取物的植物化学特征、抗毒作用及抗菌机制。
IF 5.4 2区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-02-05 DOI: 10.1016/j.jep.2026.121342
Mashilo Mash Matotoka, Talita Jessica Mnisi, Potsiso Letau Koma, Matsilane Lethabo Mashilo, Peter Masoko

Ethnopharmacological relevance

Myrothamnus flabellifolius, the “resurrection plant,” traditionally used in southern Africa, shows strong potential for anti-virulence chemotherapy and for mitigating toxin-linked pathogenesis, reinforcing its enduring ethnomedicinal value.

Aim of the study

to investigate the phytochemical composition, antibiofilm, cytoprotective and anti-haemolytic effects, and potential antibacterial mechanisms of the extracts.

Materials and methods

Simultaneous extraction of plant material was done using hexane and aqueous acetone, followed by liquid-extraction of acetone extract. LC-MS was used for chemical profiling. Antioxidant activity was assessed. Haemolytic and cytoprotective activities were investigated against hydrogen peroxide and β-haemolytic pathogens. Antibacterial activity was assessed using broth micro-dilution, dehydrogenase and cell membrane disruption assays. Antibiofilm activity was investigated using the crystal violet, tetrazolium assays and evaluation of bacterial growth.

Results

Taxifolin, eriodyctiol, quercetin were identified in the ethyl acetate subfractions of the leaves (LEA) and stems (SEA) and phytosterols in the hexane fractions of the leaves (LH) and stem (SH). LEA and SEA exhibited strong antioxidant activity and provided significant protection of erythrocytes against oxidative and pathogen-induced haemolysis. LEA and SEA were active against Pseudomonas aeruginosa (MIC = 160 μg/mL), LH showed similar activity against Staphylococcus aureus (MIC = 160 μg/mL). The extracts disrupted the bacterial cell envelopes and inhibited dehydrogenase-linked metabolisms. Sub-MIC of LH, SH, and SEA significantly reduced biofilm formation in P. aeruginosa and Streptococcus pyogenes, despite exerting minimal effects on planktonic growth.

Conclusion

M. flabellifolius shows strong multi-target antibacterial and sub-MIC antibiofilm activity, alongside notable antioxidant, cryoprotection and potential for addressing oxidative stress-linked ailments.
民族药理学意义:非洲南部传统上使用的“复活植物”Myrothamnus flabellifolius显示出抗毒化疗和减轻毒素相关发病机制的强大潜力,从而加强了其持久的民族医学价值。研究目的:探讨其植物化学成分、抗生物膜作用、细胞保护作用和抗溶血作用及其潜在的抗菌机制。材料与方法:采用正己烷和丙酮水溶液同时提取,丙酮液提取。采用LC-MS进行化学分析。测定其抗氧化活性。对过氧化氢和β-溶血病原体的溶血和细胞保护活性进行了研究。采用微量肉汤稀释法、脱氢酶法和细胞膜破坏法测定其抑菌活性。采用结晶紫法、四氮唑法和细菌生长评价法对抗菌膜活性进行了研究。结果:在叶和茎的乙酸乙酯组分(LEA)和乙酸乙酯组分(SEA)中鉴定出杉木素、叶红醇和槲皮素,在叶和茎的己烷组分(LH)和茎的己烷组分(SH)中鉴定出植物甾醇。LEA和SEA具有较强的抗氧化活性,对红细胞抗氧化和病原体诱导的溶血有显著的保护作用。LEA和SEA对铜绿假单胞菌(MIC = 160 μg/mL)有抑制作用,LH对金黄色葡萄球菌(MIC = 160 μg/mL)有抑制作用。提取物破坏细菌的细胞包膜,抑制脱氢酶相关的代谢。LH、SH和SEA的亚mic显著降低了铜绿假单胞菌和化脓性链球菌的生物膜形成,尽管对浮游生物生长的影响很小。结论:褐藻具有较强的多靶点抗菌和亚mic抗生物膜活性,并具有显著的抗氧化、低温保护和治疗氧化应激相关疾病的潜力。
{"title":"Phytochemical profiling, anti-virulence effects, and antibacterial mechanisms of Myrothamnus flabellifolius (Welw.) extracts","authors":"Mashilo Mash Matotoka,&nbsp;Talita Jessica Mnisi,&nbsp;Potsiso Letau Koma,&nbsp;Matsilane Lethabo Mashilo,&nbsp;Peter Masoko","doi":"10.1016/j.jep.2026.121342","DOIUrl":"10.1016/j.jep.2026.121342","url":null,"abstract":"<div><h3>Ethnopharmacological relevance</h3><div><em>Myrothamnus flabellifolius,</em> the “resurrection plant,” traditionally used in southern Africa, shows strong potential for anti-virulence chemotherapy and for mitigating toxin-linked pathogenesis, reinforcing its enduring ethnomedicinal value.</div></div><div><h3>Aim of the study</h3><div>to investigate the phytochemical composition, antibiofilm, cytoprotective and anti-haemolytic effects, and potential antibacterial mechanisms of the extracts.</div></div><div><h3>Materials and methods</h3><div>Simultaneous extraction of plant material was done using hexane and aqueous acetone, followed by liquid-extraction of acetone extract. LC-MS was used for chemical profiling. Antioxidant activity was assessed. Haemolytic and cytoprotective activities were investigated against hydrogen peroxide and <em>β</em>-haemolytic pathogens. Antibacterial activity was assessed using broth micro-dilution, dehydrogenase and cell membrane disruption assays. Antibiofilm activity was investigated using the crystal violet, tetrazolium assays and evaluation of bacterial growth.</div></div><div><h3>Results</h3><div>Taxifolin, eriodyctiol, quercetin were identified in the ethyl acetate subfractions of the leaves (LEA) and stems (SEA) and phytosterols in the hexane fractions of the leaves (LH) and stem (SH). LEA and SEA exhibited strong antioxidant activity and provided significant protection of erythrocytes against oxidative and pathogen-induced haemolysis. LEA and SEA were active against <em>Pseudomonas aeruginosa</em> (MIC = 160 μg/mL), LH showed similar activity against <em>Staphylococcus aureus</em> (MIC = 160 μg/mL). The extracts disrupted the bacterial cell envelopes and inhibited dehydrogenase-linked metabolisms. Sub-MIC of LH, SH, and SEA significantly reduced biofilm formation in <em>P. aeruginosa</em> and <em>Streptococcus pyogenes</em>, despite exerting minimal effects on planktonic growth.</div></div><div><h3>Conclusion</h3><div><em>M. flabellifolius</em> shows strong multi-target antibacterial and sub-MIC antibiofilm activity, alongside notable antioxidant, cryoprotection and potential for addressing oxidative stress-linked ailments.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"362 ","pages":"Article 121342"},"PeriodicalIF":5.4,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elucidating the material basis and mechanism of Shegan Mahuang decoction in inhibiting influenza virus pneumonia based on UHPLC-HRMS, network pharmacology and experimental verification 基于UHPLC-HRMS、网络药理学和实验验证,阐明蛇肝麻黄汤抑制流感病毒肺炎的物质基础和作用机制。
IF 5.4 2区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-02-05 DOI: 10.1016/j.jep.2026.121332
Xin-Ye Du , Lei Xu , Dan Liu , Zhi-Jun Zhang , Rong-Tao Li

Ethnopharmacological relevance

Shegan Mahuang Decoction (SMD), a traditional Chinese medicinal prescription outlined in “Jin Gui Yao Lue”. For approximately two thousand years, it has been widely used to treat asthma and flu-like symptoms in China and Japan for around twenty centuries. While the efficacy is confirmed, its pharmacological mechanism remains unclear.

Aim of the study

This study aimed to systematically evaluate the protective effects of SMD against influenza A virus (IAV)-induced pneumonia and explore its action mechanism.

Materials and methods

Material basis and absorbed components of SMD were analyzed using UHPLC-HRMS. Integrating absorbed components and network pharmacology to predict its potential for treating influenza and its mechanism of action. By using the IAV pneumonia model, the abilities of SMD to suppress pathogenic-evil and pneumonia were confirmed using MDCK cells and BALB/c mice.

Results

UHPLC-HRMS identified 497 components in SMD, of which 125 were absorbed into the bloodstream of mice. Network pharmacology analysis based on absorbed components indicates SMD's anti-influenza effects through multiple biological processes associated with infection and immunity. SMD can inhibit viral proliferation in vitro and protect MDCK cells. It increased survival in infected mice from 8 to over 12 days. In the mice with IAV pneumonia, SMD significantly alleviated pathological damage, reduced viral proteins and mucins in lung tissue. It also regulates cytokines including TNF-α, IL-1β, and IL-6, and inhibited the activation of TLR/TAK/NF-κB and MEK/ERK signaling pathways.

Conclusion

This study has confirmed that SMD can alleviate the hyper-inflammatory response in the host induced by IAV. It suggests that SMD can treat pneumonia by inhibiting pathogenic-evil factors.
民族药理学相关性:蛇干麻黄汤(SMD),《金桂要略》中概述的传统中药处方。在大约两千年的时间里,它在中国和日本被广泛用于治疗哮喘和类似流感的症状。虽然疗效已被证实,但其药理机制尚不清楚。研究目的:本研究旨在系统评价SMD对甲型流感病毒(IAV)诱导的肺炎的保护作用,并探讨其作用机制。材料与方法:采用UHPLC-HRMS对SMD的物质基础和吸收成分进行分析。综合吸收成分和网络药理学预测其治疗流感的潜力及其作用机制。通过IAV肺炎模型,用MDCK细胞和BALB/c小鼠证实了SMD对致病性和肺炎的抑制能力。结果:UHPLC-HRMS鉴定出SMD中497种成分,其中125种被小鼠血流吸收。基于吸收成分的网络药理学分析表明,SMD的抗流感作用是通过与感染和免疫相关的多个生物过程实现的。SMD能抑制病毒体外增殖,保护MDCK细胞。它使感染小鼠的存活率从8天增加到12天以上。在IAV肺炎小鼠中,SMD显著减轻病理性损伤,降低肺组织中的病毒蛋白和粘蛋白。调节TNF-α、IL-1β、IL-6等细胞因子,抑制TLR/TAK/NF-κB、MEK/ERK信号通路的激活。结论:本研究证实SMD可减轻IAV诱导的宿主高炎症反应。提示SMD可通过抑制病邪因子治疗肺炎。
{"title":"Elucidating the material basis and mechanism of Shegan Mahuang decoction in inhibiting influenza virus pneumonia based on UHPLC-HRMS, network pharmacology and experimental verification","authors":"Xin-Ye Du ,&nbsp;Lei Xu ,&nbsp;Dan Liu ,&nbsp;Zhi-Jun Zhang ,&nbsp;Rong-Tao Li","doi":"10.1016/j.jep.2026.121332","DOIUrl":"10.1016/j.jep.2026.121332","url":null,"abstract":"<div><h3>Ethnopharmacological relevance</h3><div>Shegan Mahuang Decoction (SMD), a traditional Chinese medicinal prescription outlined in “<em>Jin Gui Yao Lue</em>”. For approximately two thousand years, it has been widely used to treat asthma and flu-like symptoms in China and Japan for around twenty centuries. While the efficacy is confirmed, its pharmacological mechanism remains unclear.</div></div><div><h3>Aim of the study</h3><div>This study aimed to systematically evaluate the protective effects of SMD against influenza A virus (IAV)-induced pneumonia and explore its action mechanism.</div></div><div><h3>Materials and methods</h3><div>Material basis and absorbed components of SMD were analyzed using UHPLC-HRMS. Integrating absorbed components and network pharmacology to predict its potential for treating influenza and its mechanism of action. By using the IAV pneumonia model, the abilities of SMD to suppress pathogenic-evil and pneumonia were confirmed using MDCK cells and BALB/c mice.</div></div><div><h3>Results</h3><div>UHPLC-HRMS identified 497 components in SMD, of which 125 were absorbed into the bloodstream of mice. Network pharmacology analysis based on absorbed components indicates SMD's anti-influenza effects through multiple biological processes associated with infection and immunity. SMD can inhibit viral proliferation <em>in vitro</em> and protect MDCK cells. It increased survival in infected mice from 8 to over 12 days. In the mice with IAV pneumonia, SMD significantly alleviated pathological damage, reduced viral proteins and mucins in lung tissue. It also regulates cytokines including TNF-α, IL-1β, and IL-6, and inhibited the activation of TLR/TAK/NF-κB and MEK/ERK signaling pathways.</div></div><div><h3>Conclusion</h3><div>This study has confirmed that SMD can alleviate the hyper-inflammatory response in the host induced by IAV. It suggests that SMD can treat pneumonia by inhibiting pathogenic-evil factors.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"362 ","pages":"Article 121332"},"PeriodicalIF":5.4,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacological potential of chalepensin from Ruta chalepensis L.: Acute toxicity and in vivo antitumor activity in the L5178Y-R murine model chalepensis L.中chalepensis的药理潜力:对L5178Y-R小鼠模型的急性毒性和体内抗肿瘤活性。
IF 5.4 2区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-02-05 DOI: 10.1016/j.jep.2026.121334
Nancy E. Rodríguez-Garza , Ramiro Quintanilla-Licea , Diana E. Caballero-Hernández , Ana L. Delgado-Miranda , César I. Romo-Sáenz , Ricardo Gomez-Flores

Ethnopharmacological relevance

Ruta chalepensis L. (rue) is a medicinal plant commonly used in folk medicine and is known to contain bioactive secondary metabolites with pharmacological potential. Among these, chalepensin has been previously described to exhibit antitumor activity in vitro; however, its in vivo efficacy and safety profile remain poorly characterized.

Aim of the study

To evaluate the in vitro and in vivo antitumor activity of chalepensin against L5178Y-R murine lymphoma and to assess its acute toxicity profile.

Materials and methods

Chalepensin was isolated from the leaves and stems of R. chalepensis. Cytotoxic activity was determined in vitro with the MTT assay against tumor and normal cell lines. In silico analyses were performed to predict pharmacokinetic properties and explore potential molecular interactions. Acute toxicity was assessed in BALB/c mice following intraperitoneal administration of chalepensin (100 and 1000 mg/kg). Antitumor efficacy was evaluated in BALB/c mice bearing L5178Y-R lymphoma by monitoring tumor volume and survival.

Results

Chalepensin exhibited potent cytotoxic activity against L5178Y-R cells (IC50 = 8.1 μg/mL; SI = 66.5). In silico analyses predicted favorable pharmacokinetic properties. Acute toxicity studies revealed no mortality, clinical signs of toxicity, or significant alterations in biochemical and hematological parameters. In vivo, chalepensin induced a significant reduction in tumor volume between days 10 and 20 (p < 0.05) and significantly prolonged mean survival time, showing comparable or superior efficacy to vincristine under the tested conditions. Molecular docking suggested a preferential interaction with the Cyclin A2–CDK2 complex, supporting a potential cytostatic mechanism consistent with the observed in vivo effects.

Conclusion

Chalepensin demonstrates promising antitumor activity against L5178Y-R murine lymphoma, along with a favorable acute toxicity profile. These findings support its potential for further preclinical development and warrant additional studies to elucidate its molecular mechanisms and long-term safety.
民族药理学相关性:芸香是民间医学中常用的药用植物,已知含有具有药理潜力的生物活性次生代谢物。其中,chalepensin先前已被描述在体外表现出抗肿瘤活性;然而,其在体内的有效性和安全性仍不清楚。目的:研究chalepensin对小鼠L5178Y-R淋巴瘤的体内外抗肿瘤活性,并评价其急性毒性。材料与方法:从chalepensis的叶和茎中分离得到chalepensis素。用MTT法测定其对肿瘤和正常细胞株的体外细胞毒活性。通过计算机分析预测药代动力学性质并探索潜在的分子相互作用。腹腔注射chalepensin(100和1000 mg/kg)对BALB/c小鼠的急性毒性进行了评估。通过监测肿瘤体积和生存率来评价L5178Y-R淋巴瘤BALB/c小鼠的抗肿瘤疗效。结果:Chalepensin对L5178Y-R细胞具有较强的细胞毒活性(IC50 = 8.1 μg/mL, SI = 66.5)。计算机分析预测了良好的药代动力学特性。急性毒性研究未发现死亡、临床毒性症状或生化和血液学参数的显著改变。在体内,chalepensin诱导肿瘤体积在第10天至第20天显著减少(p < 0.05),平均生存时间显著延长,在试验条件下与长春新碱的疗效相当或优于长春新碱。分子对接提示与Cyclin A2-CDK2复合物优先相互作用,支持与体内观察到的效应一致的潜在细胞抑制机制。结论:Chalepensin对L5178Y-R小鼠淋巴瘤具有良好的抗肿瘤活性,并具有良好的急性毒性。这些发现支持其进一步临床前开发的潜力,并需要进一步的研究来阐明其分子机制和长期安全性。
{"title":"Pharmacological potential of chalepensin from Ruta chalepensis L.: Acute toxicity and in vivo antitumor activity in the L5178Y-R murine model","authors":"Nancy E. Rodríguez-Garza ,&nbsp;Ramiro Quintanilla-Licea ,&nbsp;Diana E. Caballero-Hernández ,&nbsp;Ana L. Delgado-Miranda ,&nbsp;César I. Romo-Sáenz ,&nbsp;Ricardo Gomez-Flores","doi":"10.1016/j.jep.2026.121334","DOIUrl":"10.1016/j.jep.2026.121334","url":null,"abstract":"<div><h3>Ethnopharmacological relevance</h3><div><em>Ruta chalepensis</em> L. (rue) is a medicinal plant commonly used in folk medicine and is known to contain bioactive secondary metabolites with pharmacological potential. Among these, chalepensin has been previously described to exhibit antitumor activity <em>in vitro</em>; however, its <em>in vivo</em> efficacy and safety profile remain poorly characterized.</div></div><div><h3>Aim of the study</h3><div>To evaluate the <em>in vitro</em> and <em>in vivo</em> antitumor activity of chalepensin against L5178Y-R murine lymphoma and to assess its acute toxicity profile.</div></div><div><h3>Materials and methods</h3><div>Chalepensin was isolated from the leaves and stems of <em>R. chalepensis</em>. Cytotoxic activity was determined <em>in vitro</em> with the MTT assay against tumor and normal cell lines. <em>In silico</em> analyses were performed to predict pharmacokinetic properties and explore potential molecular interactions. Acute toxicity was assessed in BALB/c mice following intraperitoneal administration of chalepensin (100 and 1000 mg/kg). Antitumor efficacy was evaluated in BALB/c mice bearing L5178Y-R lymphoma by monitoring tumor volume and survival.</div></div><div><h3>Results</h3><div>Chalepensin exhibited potent cytotoxic activity against L5178Y-R cells (IC<sub>50</sub> = 8.1 μg/mL; SI = 66.5). <em>In silico</em> analyses predicted favorable pharmacokinetic properties. Acute toxicity studies revealed no mortality, clinical signs of toxicity, or significant alterations in biochemical and hematological parameters. <em>In vivo</em>, chalepensin induced a significant reduction in tumor volume between days 10 and 20 (p &lt; 0.05) and significantly prolonged mean survival time, showing comparable or superior efficacy to vincristine under the tested conditions. Molecular docking suggested a preferential interaction with the Cyclin A2–CDK2 complex, supporting a potential cytostatic mechanism consistent with the observed <em>in vivo</em> effects.</div></div><div><h3>Conclusion</h3><div>Chalepensin demonstrates promising antitumor activity against L5178Y-R murine lymphoma, along with a favorable acute toxicity profile. These findings support its potential for further preclinical development and warrant additional studies to elucidate its molecular mechanisms and long-term safety.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"362 ","pages":"Article 121334"},"PeriodicalIF":5.4,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating transcriptomics and metabolomics to explore the therapeutic effects and mechanisms of Zhushagen-Shandougen herb pair on chronic pharyngitis 结合转录组学和代谢组学,探讨竹下根-山根根对慢性咽炎的治疗作用及机制。
IF 5.4 2区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-02-05 DOI: 10.1016/j.jep.2026.121291
Yun Chen , Hui Shi , Zhou-Jie Yang , Xiong-wei Liu , Li-Yan zhang , Xiu Dong , Xing-Yan Ma , Ying Zhou , Ting-Ting Feng

Ethnopharmacological relevance

Ardisia crenata Sims (Zhushagen) and Sophora tonkinensis Gagnep. (Shandougen), core components of Kaihoujian Spray, are used in Miao medicine to treat chronic pharyngitis (CP), but their mechanisms remain unclear.

Aim of the study

This study aimed to investigate the therapeutic effects of Zhushagen, Shandougen, and their combination (Zhushagen-Shandougen) on CP, and to elucidate the pharmacological mechanisms via serum metabolomics and pharyngeal mucosa transcriptomics.

Methods

A rat model of chronic pharyngitis was induced by ammonium hydroxide administration. Therapeutic effects were evaluated via behavioral assessment, histopathological examination, and ELISA for inflammatory cytokines. For mechanism exploration, transcriptomic analysis of pharyngeal mucosa and metabolomic analysis of serum were performed in rats. Correlation analysis was used to integrate transcriptomic and metabolomic data, and a core regulatory network was constructed based on key genes, metabolites, and pathways. Potential targets were validated by immunohistochemistry and RT-qPCR.

Results

All treatments dose-dependently ameliorated CP symptoms, reduced the pro-inflammatory cytokines IL-1β, IL-6, PGE2, and TNF-α, increased IL-10, and alleviated mucosal lesions, with the combination being the most potent. In omics analyses, 32 differential metabolites and 121 differential mRNAs were identified. KEGG enrichment showed that differential metabolites were primarily involved in riboflavin and glutathione metabolism, while differential mRNAs were enriched in the MAPK and PI3K-Akt signaling pathways. RT-qPCR validation of 9 genes confirmed the transcriptomic results; notably, the mRNA expressions of p38, erk1/2, pi3k, and akt were altered. Immunohistochemistry further confirmed changes in the protein levels of p38, ERK1/2, and Akt, as well as the activations of p38 and PI3K, validating the omics findings.

Conclusion

Zhushagen, Shandougen, and Zhushagen-Shandougen exert therapeutic effects on CP. The present study found that Zhushagen-Shandougen may suppress the PI3K/Akt and MAPK signaling pathways, thus alleviating ammonium hydroxide-induced CP. The elucidated mechanism provides a significant theoretical foundation and a novel therapeutic approach for the treatment of CP.
民族药理学相关性:朱哈根红荆芥和东京苦参。山根茎是开后健喷雾剂的核心成分,在苗族医学中用于治疗慢性咽炎,但其作用机制尚不清楚。研究目的:本研究旨在观察竹海根、山根根及其联合用药(竹海根-山根根)对慢性慢性胰腺炎的治疗作用,并通过血清代谢组学和咽黏膜转录组学研究其作用机制。方法:采用氢氧化铵诱导大鼠慢性咽炎模型。通过行为评估、组织病理学检查和ELISA检测炎症细胞因子来评估治疗效果。为探讨机制,对大鼠进行了咽黏膜转录组学分析和血清代谢组学分析。利用相关分析整合转录组学和代谢组学数据,构建基于关键基因、代谢物和通路的核心调控网络。通过免疫组织化学和RT-qPCR验证潜在靶点。结果:所有治疗均有剂量依赖性地改善CP症状,降低促炎因子IL-1β、IL-6、PGE2和TNF-α,升高IL-10,减轻粘膜病变,以联合治疗效果最好。在组学分析中,鉴定出32种差异代谢物和121种差异mrna。KEGG富集表明差异代谢物主要参与核黄素和谷胱甘肽代谢,而差异mrna富集于MAPK和PI3K-Akt信号通路。9个基因的RT-qPCR验证证实了转录组学结果;p38、erk1/2、pi3k、akt mRNA表达明显改变。免疫组织化学进一步证实了p38、ERK1/2和Akt蛋白水平的变化,以及p38和PI3K的激活,验证了组学研究结果。结论:竹海根、山根根、竹海根-山根根对脑瘫有一定的治疗作用,本研究发现竹海根-山根根可能抑制PI3K/Akt和MAPK信号通路,从而减轻氢氧化铵诱导的脑瘫,其机制的阐明为脑瘫的治疗提供了重要的理论基础和新的治疗途径。
{"title":"Integrating transcriptomics and metabolomics to explore the therapeutic effects and mechanisms of Zhushagen-Shandougen herb pair on chronic pharyngitis","authors":"Yun Chen ,&nbsp;Hui Shi ,&nbsp;Zhou-Jie Yang ,&nbsp;Xiong-wei Liu ,&nbsp;Li-Yan zhang ,&nbsp;Xiu Dong ,&nbsp;Xing-Yan Ma ,&nbsp;Ying Zhou ,&nbsp;Ting-Ting Feng","doi":"10.1016/j.jep.2026.121291","DOIUrl":"10.1016/j.jep.2026.121291","url":null,"abstract":"<div><h3>Ethnopharmacological relevance</h3><div><em>Ardisia crenata</em> Sims (Zhushagen) and <em>Sophora tonkinensis</em> Gagnep. (Shandougen), core components of Kaihoujian Spray, are used in Miao medicine to treat chronic pharyngitis (CP), but their mechanisms remain unclear.</div></div><div><h3>Aim of the study</h3><div>This study aimed to investigate the therapeutic effects of Zhushagen, Shandougen, and their combination (Zhushagen-Shandougen) on CP, and to elucidate the pharmacological mechanisms via serum metabolomics and pharyngeal mucosa transcriptomics.</div></div><div><h3>Methods</h3><div>A rat model of chronic pharyngitis was induced by ammonium hydroxide administration. Therapeutic effects were evaluated via behavioral assessment, histopathological examination, and ELISA for inflammatory cytokines. For mechanism exploration, transcriptomic analysis of pharyngeal mucosa and metabolomic analysis of serum were performed in rats. Correlation analysis was used to integrate transcriptomic and metabolomic data, and a core regulatory network was constructed based on key genes, metabolites, and pathways. Potential targets were validated by immunohistochemistry and RT-qPCR.</div></div><div><h3>Results</h3><div>All treatments dose-dependently ameliorated CP symptoms, reduced the pro-inflammatory cytokines IL-1β, IL-6, PGE2, and TNF-α, increased IL-10, and alleviated mucosal lesions, with the combination being the most potent. In omics analyses, 32 differential metabolites and 121 differential mRNAs were identified. KEGG enrichment showed that differential metabolites were primarily involved in riboflavin and glutathione metabolism, while differential mRNAs were enriched in the MAPK and PI3K-Akt signaling pathways. RT-qPCR validation of 9 genes confirmed the transcriptomic results; notably, the mRNA expressions of <em>p38</em>, <em>erk1/2</em>, <em>pi3k</em>, and <em>akt</em> were altered. Immunohistochemistry further confirmed changes in the protein levels of p38, ERK1/2, and Akt, as well as the activations of p38 and PI3K, validating the omics findings.</div></div><div><h3>Conclusion</h3><div>Zhushagen, Shandougen, and Zhushagen-Shandougen exert therapeutic effects on CP. The present study found that Zhushagen-Shandougen may suppress the PI3K/Akt and MAPK signaling pathways, thus alleviating ammonium hydroxide-induced CP. The elucidated mechanism provides a significant theoretical foundation and a novel therapeutic approach for the treatment of CP.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"362 ","pages":"Article 121291"},"PeriodicalIF":5.4,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid antidepressant effects of Aurantii Fructus are mediated by hypoxanthine-caspase-4 axis in CUMS mice 次黄嘌呤-caspase-4轴介导枳实对CUMS小鼠的快速抗抑郁作用。
IF 5.4 2区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-02-04 DOI: 10.1016/j.jep.2026.121330
Chao Lu, Liyuan Tian, Zixuan Wei, Yiran Jiang, Mengqi Shao, Yaping Zhu, Lei Wu

Ethnopharmacological relevancy

Aurantii Fructus (AF)is a traditional Chinese medicine historically used to regulate Qi and alleviate emotional distress, suggesting potential psychotropic effects. This study investigates its therapeutic value for depression based on this traditional indication.

Aim of the study

To evaluate the rapid antidepressant-like effect of a single acute dose of AF extract in a chronic unpredictable mild stress (CUMS) mouse model and elucidate its underlying molecular mechanisms through integrated transcriptomic and metabolomic analyses.

Materials and methods

AF flavonoid content was quantified by HPLC. Male mice underwent a 4-week CUMS protocol. A single oral dose of AF was administered 2 h prior to behavioral testing (NSF, TST, SPT, and OFT), with ketamine serving as a positive control. Hippocampal transcriptome analysis was performed by RNA sequencing, and serum metabolites were profiled via LC-MS in both positive and negative ion modes. Pearson correlation analysis assessed relationships between key targets and behavioral outcomes. Pathway involvement was functionally validated in a separate experiment using a hypoxanthine synthesis inhibitor.

Results

AF contained narirutin (1.32 mg/g), hesperidin (3.19 mg/g), neohesperidin (22.89 mg/g), naringenin (0.03 mg/g), and nobiletin (0.08 mg/g). Acute AF administration rapidly reversed CUMS-induced depressive-like behaviors, significantly decreasing latency to feed and increasing food consumption in the NSF test, reducing immobility time in the TST, and elevating sucrose preference in the SPT, without altering locomotor activity. Transcriptomic analysis revealed specific downregulation of hippocampal caspase-4 expression by AF. Metabolomic profiling showed AF normalized elevated serum hypoxanthine levels. Serum hypoxanthine levels negatively correlated with hippocampal caspase-4 expression and behavioral improvements, whereas caspase-4 expression positively correlated with behavioral deficits. Pharmacological inhibition of hypoxanthine synthesis abolished AF's antidepressant effects and prevented its normalization of hippocampal caspase-4, NF-κB, GDNF, and BDNF expression.

Conclusions

Acute AF produces rapid, ketamine-like antidepressant effects by targeting the hypoxanthine-caspase-4 pathway. This study reveals a novel purinergic mechanism underlying AF's traditional use for emotional disorders and offers a promising therapeutic strategy for rapid-acting antidepressant development.
民族药理学相关性:Aurantii Fructus (AF)是一种历史上用于调节气和缓解情绪困扰的中药,表明其潜在的精神药物作用。本研究在此传统适应症的基础上探讨其治疗抑郁症的价值。研究目的:在慢性不可预测轻度应激(CUMS)小鼠模型中评估单次急性剂量AF提取物的快速抗抑郁样作用,并通过综合转录组学和代谢组学分析阐明其潜在的分子机制。材料与方法:采用高效液相色谱法测定AF类黄酮含量。雄性小鼠接受为期4周的CUMS方案。在行为测试(NSF、TST、SPT和OFT)前2小时口服单剂量房颤,氯胺酮作为阳性对照。通过RNA测序进行海马转录组分析,并通过LC-MS在正离子和负离子模式下分析血清代谢物。Pearson相关分析评估了关键目标与行为结果之间的关系。在使用次黄嘌呤合成抑制剂的单独实验中,途径参与在功能上得到了验证。结果:AF中含有萘啶苷(1.32 mg/g)、橙皮苷(3.19 mg/g)、新橙皮苷(22.89 mg/g)、柚皮苷(0.03 mg/g)、去皮苷(0.08 mg/g)。急性AF迅速逆转了cms诱导的抑郁样行为,显著降低了NSF测试中的进食延迟和食物消耗,减少了TST中的静止时间,提高了SPT中的蔗糖偏好,而不改变运动活动。转录组学分析显示AF特异性下调海马caspase-4表达。代谢组学分析显示AF使血清次黄嘌呤水平升高正常化。血清次黄嘌呤水平与海马caspase-4表达和行为改善呈负相关,而caspase-4表达与行为缺陷呈正相关。药物抑制次黄嘌呤合成可消除AF的抗抑郁作用,并阻止其海马caspase-4、NF-κB、GDNF和BDNF表达的正常化。结论:急性房颤通过靶向次黄嘌呤-caspase-4通路产生快速的、类似氯胺酮的抗抑郁作用。这项研究揭示了一种新的嘌呤能机制,它隐藏在房颤传统上用于情绪障碍的基础上,并为开发速效抗抑郁药提供了一种有希望的治疗策略。
{"title":"Rapid antidepressant effects of Aurantii Fructus are mediated by hypoxanthine-caspase-4 axis in CUMS mice","authors":"Chao Lu,&nbsp;Liyuan Tian,&nbsp;Zixuan Wei,&nbsp;Yiran Jiang,&nbsp;Mengqi Shao,&nbsp;Yaping Zhu,&nbsp;Lei Wu","doi":"10.1016/j.jep.2026.121330","DOIUrl":"10.1016/j.jep.2026.121330","url":null,"abstract":"<div><h3>Ethnopharmacological relevancy</h3><div>Aurantii Fructus (AF)is a traditional Chinese medicine historically used to regulate Qi and alleviate emotional distress, suggesting potential psychotropic effects. This study investigates its therapeutic value for depression based on this traditional indication.</div></div><div><h3>Aim of the study</h3><div>To evaluate the rapid antidepressant-like effect of a single acute dose of AF extract in a chronic unpredictable mild stress (CUMS) mouse model and elucidate its underlying molecular mechanisms through integrated transcriptomic and metabolomic analyses.</div></div><div><h3>Materials and methods</h3><div>AF flavonoid content was quantified by HPLC. Male mice underwent a 4-week CUMS protocol. A single oral dose of AF was administered 2 h prior to behavioral testing (NSF, TST, SPT, and OFT), with ketamine serving as a positive control. Hippocampal transcriptome analysis was performed by RNA sequencing, and serum metabolites were profiled via LC-MS in both positive and negative ion modes. Pearson correlation analysis assessed relationships between key targets and behavioral outcomes. Pathway involvement was functionally validated in a separate experiment using a hypoxanthine synthesis inhibitor.</div></div><div><h3>Results</h3><div>AF contained narirutin (1.32 mg/g), hesperidin (3.19 mg/g), neohesperidin (22.89 mg/g), naringenin (0.03 mg/g), and nobiletin (0.08 mg/g). Acute AF administration rapidly reversed CUMS-induced depressive-like behaviors, significantly decreasing latency to feed and increasing food consumption in the NSF test, reducing immobility time in the TST, and elevating sucrose preference in the SPT, without altering locomotor activity. Transcriptomic analysis revealed specific downregulation of hippocampal caspase-4 expression by AF. Metabolomic profiling showed AF normalized elevated serum hypoxanthine levels. Serum hypoxanthine levels negatively correlated with hippocampal caspase-4 expression and behavioral improvements, whereas caspase-4 expression positively correlated with behavioral deficits. Pharmacological inhibition of hypoxanthine synthesis abolished AF's antidepressant effects and prevented its normalization of hippocampal caspase-4, NF-κB, GDNF, and BDNF expression.</div></div><div><h3>Conclusions</h3><div>Acute AF produces rapid, ketamine-like antidepressant effects by targeting the hypoxanthine-caspase-4 pathway. This study reveals a novel purinergic mechanism underlying AF's traditional use for emotional disorders and offers a promising therapeutic strategy for rapid-acting antidepressant development.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"362 ","pages":"Article 121330"},"PeriodicalIF":5.4,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Luteolin, a bioactive compound from Celastrus orbiculatus stem, inhibits cervical cancer via CA2 suppression: A translational study bridging basic research and clinical application 木犀草素是一种来自环青藤茎的生物活性化合物,通过抑制CA2抑制宫颈癌:一项基础研究和临床应用的转化研究。
IF 5.4 2区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-02-04 DOI: 10.1016/j.jep.2026.121326
Jue Chen , MengKe Wu , RongRong Zhang , Yun Cao , Xiangyan Chen , Xinyu Liu , Yanqing Liu , Wei Jiang , Qiang Wang
<div><h3>Ethnopharmacological relevance</h3><div><em>Celastrus orbiculatus</em> Thunb. is a traditional herb with the effects of eliminating wind and dampness, activating blood circulation and detoxifying.It is commonly used in the treatment of malignant tumors and rheumatoid arthritis in China. Previous basic research has confirmed its significant anti-tumor activity. However, the underlying mechanism of its treatment in cervical cancer has not been reported.</div></div><div><h3>Aim of the study</h3><div>Building on findings from a retrospective clinical analysis, this study applied bioinformatics and experimental validation to elucidate the mechanism by which luteolin, a major constituent of <em>Celastrus orbiculatus</em> stem, and its target protein Carbonic Anhydrase II (CA2) exert inhibitory effects on cervical cancer.</div></div><div><h3>Methods</h3><div>A retrospective clinical analysis was first conducted to assess the impact of <em>Celastrus orbiculatus</em> stem (30 g/day) combined with postoperative concurrent chemoradiotherapy (weekly cisplatin) on recurrence in cervical cancer patients. Liquid chromatography–mass spectrometry (LC–MS) was then used to identify the principal active components of <em>Celastrus orbiculatus</em> stem. Public databases were employed to determine the core targets of these active components against cervical cancer. Prognostic analysis was performed using data from The Cancer Genome Atlas (TCGA). Expression of core target proteins was validated in clinical surgical specimens of cervical cancer. Finally, the inhibitory effects of the identified active compound (luteolin) acting through the target protein (CA2) were confirmed using lactate dehydrogenase (LDH) release assays, gene expression modulation, and a murine xenograft tumor model.</div></div><div><h3>Results</h3><div>Retrospective clinical analysis demonstrated that <em>Celastrus orbiculatus</em> stem (30 g/day) combined with weekly cisplatin concurrent radiotherapy significantly prolonged postoperative disease-free survival in cervical cancer patients. In vitro, the extract of <em>Celastrus orbiculatus</em> stem suppressed cervical cancer cell proliferation. Luteolin was identified as a major constituent of the extract. Further analysis revealed that CA2 was characteristically overexpressed in epithelial tumor cells of cervical cancer tissues, but not in stromal cells, and served as a core target of luteolin. Modulation of CA2 expression or luteolin-mediated intervention effectively inhibited cervical cancer cell proliferation and invasion, promoted apoptosis in vitro, and suppressed the growth of xenograft tumors in vivo.</div></div><div><h3>Conclusion</h3><div>Luteolin is the primary bioactive constituent of <em>Celastrus orbiculatus</em> stem responsible for its inhibitory effects on cervical cancer. CA2, characteristically overexpressed in epithelial-derived cervical cancer cells, plays a pivotal role in promoting cancer cell proliferation and invas
民族药理学相关性:大黄芹。是一种具有祛风湿、活血解毒功效的传统草药。在中国,它常用于治疗恶性肿瘤和类风湿关节炎。前期基础研究证实其具有显著的抗肿瘤活性。然而,其治疗宫颈癌的潜在机制尚未报道。研究目的:在回顾性临床分析的基础上,应用生物信息学和实验验证的方法,探讨了鹿茸主干主要成分木犀草素及其靶蛋白碳酸酐酶II (CA2)对宫颈癌的抑制作用机制。方法:首先进行回顾性临床分析,评估轮青藤茎(30 g/d)联合术后同步放化疗(每周一次顺铂)对宫颈癌患者复发的影响。采用液相色谱-质谱法(LC-MS)对蛇蛇藤茎中的主要有效成分进行了鉴定。利用公共数据库确定这些有效成分对抗子宫颈癌的核心目标。预后分析使用来自癌症基因组图谱(TCGA)的数据。核心靶蛋白的表达在宫颈癌临床手术标本中得到验证。最后,鉴定的活性化合物(木犀草素)通过靶蛋白(CA2)的抑制作用通过乳酸脱氢酶(LDH)释放测定、基因表达调节和小鼠异种移植肿瘤模型得到证实。结果:回顾性临床分析表明,轮青藤茎(30 g/天)联合每周顺铂同步放疗可显著延长宫颈癌患者术后无病生存期。在体外实验中,环蛇藤茎提取物对宫颈癌细胞增殖有抑制作用。木犀草素是该提取物的主要成分。进一步分析发现,CA2在宫颈癌组织的上皮肿瘤细胞中特征性地过表达,而在基质细胞中不表达,并且是木犀草素的核心靶点。在体外通过调节CA2表达或木犀草素介导干预可有效抑制宫颈癌细胞的增殖和侵袭,促进细胞凋亡,在体内可抑制异种移植瘤的生长。结论:木犀草素是环蛇藤抗宫颈癌的主要生物活性成分。CA2在上皮来源的宫颈癌细胞中过度表达,在促进癌细胞增殖和侵袭中起关键作用。木犀草素主要通过靶向和调节CA2表达发挥其抗癌活性,强调CA2是潜在的治疗靶点。
{"title":"Luteolin, a bioactive compound from Celastrus orbiculatus stem, inhibits cervical cancer via CA2 suppression: A translational study bridging basic research and clinical application","authors":"Jue Chen ,&nbsp;MengKe Wu ,&nbsp;RongRong Zhang ,&nbsp;Yun Cao ,&nbsp;Xiangyan Chen ,&nbsp;Xinyu Liu ,&nbsp;Yanqing Liu ,&nbsp;Wei Jiang ,&nbsp;Qiang Wang","doi":"10.1016/j.jep.2026.121326","DOIUrl":"10.1016/j.jep.2026.121326","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Ethnopharmacological relevance&lt;/h3&gt;&lt;div&gt;&lt;em&gt;Celastrus orbiculatus&lt;/em&gt; Thunb. is a traditional herb with the effects of eliminating wind and dampness, activating blood circulation and detoxifying.It is commonly used in the treatment of malignant tumors and rheumatoid arthritis in China. Previous basic research has confirmed its significant anti-tumor activity. However, the underlying mechanism of its treatment in cervical cancer has not been reported.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Aim of the study&lt;/h3&gt;&lt;div&gt;Building on findings from a retrospective clinical analysis, this study applied bioinformatics and experimental validation to elucidate the mechanism by which luteolin, a major constituent of &lt;em&gt;Celastrus orbiculatus&lt;/em&gt; stem, and its target protein Carbonic Anhydrase II (CA2) exert inhibitory effects on cervical cancer.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;A retrospective clinical analysis was first conducted to assess the impact of &lt;em&gt;Celastrus orbiculatus&lt;/em&gt; stem (30 g/day) combined with postoperative concurrent chemoradiotherapy (weekly cisplatin) on recurrence in cervical cancer patients. Liquid chromatography–mass spectrometry (LC–MS) was then used to identify the principal active components of &lt;em&gt;Celastrus orbiculatus&lt;/em&gt; stem. Public databases were employed to determine the core targets of these active components against cervical cancer. Prognostic analysis was performed using data from The Cancer Genome Atlas (TCGA). Expression of core target proteins was validated in clinical surgical specimens of cervical cancer. Finally, the inhibitory effects of the identified active compound (luteolin) acting through the target protein (CA2) were confirmed using lactate dehydrogenase (LDH) release assays, gene expression modulation, and a murine xenograft tumor model.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Retrospective clinical analysis demonstrated that &lt;em&gt;Celastrus orbiculatus&lt;/em&gt; stem (30 g/day) combined with weekly cisplatin concurrent radiotherapy significantly prolonged postoperative disease-free survival in cervical cancer patients. In vitro, the extract of &lt;em&gt;Celastrus orbiculatus&lt;/em&gt; stem suppressed cervical cancer cell proliferation. Luteolin was identified as a major constituent of the extract. Further analysis revealed that CA2 was characteristically overexpressed in epithelial tumor cells of cervical cancer tissues, but not in stromal cells, and served as a core target of luteolin. Modulation of CA2 expression or luteolin-mediated intervention effectively inhibited cervical cancer cell proliferation and invasion, promoted apoptosis in vitro, and suppressed the growth of xenograft tumors in vivo.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Luteolin is the primary bioactive constituent of &lt;em&gt;Celastrus orbiculatus&lt;/em&gt; stem responsible for its inhibitory effects on cervical cancer. CA2, characteristically overexpressed in epithelial-derived cervical cancer cells, plays a pivotal role in promoting cancer cell proliferation and invas","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"362 ","pages":"Article 121326"},"PeriodicalIF":5.4,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of ethnopharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1